Cyteir Therapeutics, Inc. (CYT)


Stock Price Forecast

March 19, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Cyteir Therapeutics, Inc. chart...

About the Company

We do not have any company description for Cyteir Therapeutics, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

42

Exchange

Nasdaq

$M

Total Revenue

42

Employees

$109M

Market Capitalization

-3.34

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $CYT News

Cyteir Therapeutics Inc CYTT

5d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Cyteir Announces Timeline for Voluntarily Delisting from Nasdaq

1mon ago, source: Stockhouse

Cyteir Therapeutics, Inc. (“Cyteir”) (Nasdaq: CYT) today announced that it has formally notified The Nasdaq Stock Market (“Nasdaq”) of its intent to delist ...

Cyteir Therapeutics executive buys $503k in company stock

29d ago, source: Investing

Cyteir Therapeutics, Inc. (NASDAQ:CYT) has reported a significant purchase of its shares by a top executive, according to a recent filing with the Securities and Exchange Commission. Braden ...

Cyteir Therapeutics, Inc. (CYT) stock forecast and price target

2y ago, source: Yahoo Finance

Find the latest Cyteir Therapeutics, Inc. CYT analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Cyteir Therapeutics to delist from Nasdaq

1mon ago, source: Investing

LEXINGTON, Mass. - Cyteir Therapeutics, Inc. (NASDAQ:CYT), a biotechnology company, announced its decision to voluntarily delist its common stock from the Nasdaq Global Select Market. The company ...

ALGS Aligos Therapeutics, Inc.

11h ago, source: Seeking Alpha

Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in viral and liver diseases. Its drug ...

ANTX AN2 Therapeutics, Inc.

10h ago, source: Seeking Alpha

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, which is in ...

Cyteir Therapeutics, Inc. (CYTT)

1mon ago, source: Nasdaq

Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings ...

Cyteir Therapeutics, Inc. (CYTT)

1mon ago, source: Nasdaq

Nasdaq provides company’s SEC filings, which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia. The SEC ...

Cyteir Therapeutics, Inc. (CYTT)

1mon ago, source: Yahoo Finance

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...